Bristol-Myers Squibb Company (BMY)
Drug Manufacturers - General · Healthcare · $110.6B
Intrinsic Value (Consensus)
$50.02
Current Price
$54.02
Margin of Safety
-7.4%
7.4% Above Intrinsic Value
Value: $50
Price: $54
Valuation Model Estimates
Current Price: $54.02
DCF (Discounted Cash Flow)
$60.55
Graham Number
$26.18
Earnings Power Value
$46.08
Relative Value (P/E)
$67.27
Dividend Discount Model
$15.19
Consensus Value
$50.02
Model Assumptions
Discount Rate
10.3%
Growth Rate
3.1%
Terminal Growth
2.5%
Risk-Free Rate
4.3%
Discount rate derived from CAPM (risk-free rate + beta × market risk premium). Growth rate based on trailing earnings growth, capped at 20%.
Health Score
C
54
Profitability
25/25
Strength
13/25
Valuation
12/25
Growth
4/25
Financial Health Signals
Very high debt — Debt/Equity ratio is 243% (above 200% is risky)
Declining revenue — top line is shrinking
Strong profitability — ROE of 38% (above 20% is excellent)
High free cash flow yield (11.6%) — generating lots of cash relative to price
Key Financials
- EPS (TTM)
- $3.36
- EPS (Forward)
- $3.47
- Book Value
- $9.06
- P/E Ratio
- 16.5
- Forward P/E
- 15.7
- PEG Ratio
- —
- ROE
- 38.2%
- Debt/Equity
- 243%
- Revenue Growth
- -0.2%
- Earnings Growth
- 3.1%
- Dividend Yield
- 1.1%
- Beta
- 0.24
Similar Stocks (Healthcare)
ABEOAbeona Therapeutics ...
$37.06+300%
ABUSArbutus Biopharma Co...
$18.93+300%
ADVBAdvanced Biomed Inc....
$26.66+300%
AGENAgenus Inc.
$20.19+300%
ATRAAtara Biotherapeutic...
$41.43+300%
Data last updated: 2026-06-21
Source: Yahoo Finance